High rate of discontinuations of highly active antiretroviral therapy as a result of antiretroviral intolerance in clinical practice: missed opportunities for adherence support?

This publication has 12 references indexed in Scilit:

• Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study
  International Journal of STD & AIDS, 2001
• Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor–Naive HIV-Infected Patients
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre
  AIDS, 2001
• Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus–Infected Cohort
  Archives of internal medicine (1960), 2000
• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients
  AIDS, 2000
• Predictors of optimal virological response to potent antiretroviral therapy
  AIDS, 1999
• Outcome and Predictors of Failure of Highly Active Antiretroviral Therapy: One‐Year Follow‐Up of a Cohort of Human Immunodeficiency Virus Type 1–Infected Persons
  The Journal of Infectious Diseases, 1999
• Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• Switching HIV-1 Protease Inhibitor Therapy: Which? When? And Why?
  Archives of internal medicine (1960), 1999